Advanced Search

Study Preview



Study Title and Description

Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial.



Key Questions Addressed
3 In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial.
Author Gaston RS., Kaplan B., Shah T., Cibrik D., Shaw LM., Angelis M., Mulgaonkar S., Meier-Kriesche HU., Patel D., Bloom RD.
Country University of Alabama at Birmingham, Birmingham, AL, USA. rgaston@uab.edu
Year 2009
Numbers Pubmed ID: 19459794
1955 (internal)

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Comparative Effectiveness of Regimens


Results & Comparisons

No Results found.